ITU Unit Action

ALEVEX

Bayer HealthCare LLC

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 88656051 FILING DATE 10/16/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY ELLIOTT, LASHAWNDA E
L.O. ASSIGNED N70-NOT FOUND

PUB INFORMATION

RUN DATE 10/23/2020
PUB DATE 03/03/2020
STATUS 730-FIRST EXTENSION - GRANTED
STATUS DATE 10/21/2020
LITERAL MARK ELEMENT ALEVEX

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT ALEVEX
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Bayer HealthCare LLC
ADDRESS 100 Bayer Boulevard
Whippany, NJ 07981
ENTITY 16-LTD LIAB CO
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 003
          DESCRIPTION TEXT Non-medicated skin care preparations
INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Preparation for the relief of pain; Topical analgesics; Transdermal patches featuring a nonsteroidal anti-inflammatory for use in treating pain, headaches, fever, inflammation, common cold symptoms, and joint stiffness; Transdermal patches for use in the treatment of pain, headaches, fever, inflammation, common cold symptoms, and joint stiffness

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 003 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
10/23/2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 014
10/21/2020 EX1G S EXTENSION 1 GRANTED 013
10/21/2020 EXT1 S EXTENSION 1 FILED 012
10/21/2020 EEXT I TEAS EXTENSION RECEIVED 011
04/28/2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 010
03/03/2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 009
03/03/2020 PUBO A PUBLISHED FOR OPPOSITION 008
02/14/2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED 007
02/14/2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED 006
02/12/2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 005
01/29/2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 004
01/23/2020 DOCK D ASSIGNED TO EXAMINER 003
10/19/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
10/19/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Sondra Schol
CORRESPONDENCE ADDRESS Sondra Schol
Bayer U.S. LLC
800 North Lindbergh Blvd., E2NA
St. Louis MO 63167
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Bayer HealthCare LLC
ADDRESS 100 Bayer Boulevard
Whippany, NJ 07981
ENTITY 16-LTD LIAB CO
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed